Login
$REGN
$953.36 +$0.96 (0.1%) After hours

Insider Transactions

What REGENERON PHARMACEUTICALS, INC.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 0 0
Sells 60 134
Total trades 82 200

Shares traded

3 months 12 months
Acquired 90,998 516,614
Disposed 95,749 482,636
Net activity −4,751 +33,978

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
Pitofsky Jason SVP Controller Nov 04 Open-market sale · S Common Stock −179 $950.76 −$170K 0
Pitofsky Jason SVP Controller Nov 04 Open-market sale · S Common Stock −35 $945.61 −$33.1K 4,272
Pitofsky Jason SVP Controller Nov 04 Open-market sale · S Common Stock −108 $944.22 −$102K 4,307
Pitofsky Jason SVP Controller Nov 04 Open-market sale · S Common Stock −529 $943.53 −$499K 4,415
Pitofsky Jason SVP Controller Nov 04 Open-market sale · S Common Stock −1,215 $942.31 −$1.14M 4,944
Pitofsky Jason SVP Controller Nov 04 Open-market sale · S Common Stock −982 $941.58 −$925K 6,159
Pitofsky Jason SVP Controller Nov 04 Open-market sale · S Common Stock −575 $940.46 −$541K 7,141
Pitofsky Jason SVP Controller Nov 04 Open-market sale · S Common Stock −439 $939.57 −$412K 7,716
Pitofsky Jason SVP Controller Nov 04 Exercise / conversion · M Common Stock +905 $492.00 +$445K 8,155
Pitofsky Jason SVP Controller Nov 04 Exercise / conversion · M Common Stock +1,478 $644.54 +$953K 7,250
Pitofsky Jason SVP Controller Nov 04 Exercise / conversion · M Common Stock +1,500 $726.53 +$1.09M 5,772
Murphy Andrew J Co-Chief Scientific Officer Nov 03 Gift · G Common Stock −1,054 — — 46,779
Zoghbi Huda Y Director Nov 03 Open-market sale · S Common Stock −500 $971.06 −$486K 1,703
Zoghbi Huda Y Director Nov 03 Open-market sale · S Common Stock −6,939 $970.42 −$6.73M 2,203
Zoghbi Huda Y Director Nov 03 Exercise / conversion · M Common Stock +7,439 $380.95 +$2.83M 9,142
Fenimore Christopher R. EVP Finance CFO Nov 02 Gift · G Common Stock −15 — — 21,726
Fenimore Christopher R. EVP Finance CFO Nov 02 Withheld — tax / exercise cost · F Common Stock −4,243 $950.50 −$4.03M 21,741
Fenimore Christopher R. EVP Finance CFO Nov 02 Exercise / conversion · M Common Stock +6,000 $381.92 +$2.29M 25,984
Larosa Joseph J EVP General Counsel and Secret Nov 02 Open-market sale · S Common Stock −527 $966.11 −$509K 38,906
Larosa Joseph J EVP General Counsel and Secret Nov 02 Open-market sale · S Common Stock −3,939 $965.41 −$3.8M 39,433

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support